Your browser doesn't support javascript.
loading
Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.
Auld, Andrew F; Blain, Michela; Ekra, Kunomboa Alexandre; Kouakou, Joseph Sylvain; Ettiègne-Traoré, Virginie; Tuho, Moise Zanga; Mohamed, Fayama; Shiraishi, Ray W; Sabatier, Jennifer; Essombo, Joseph; Adjorlolo-Johnson, Georgette; Marlink, Richard; Ellerbrock, Tedd V.
Afiliación
  • Auld AF; Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Blain M; Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Ekra KA; Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Abidjan, Côte d'Ivoire.
  • Kouakou JS; Elizabeth Glaser Pediatric AIDS Foundation, Abidjan, Côte d'Ivoire.
  • Ettiègne-Traoré V; Ministry of Health, National Program for Medical Care of Persons Living with HIV/AIDS, Abidjan, Côte d'Ivoire.
  • Tuho MZ; Ministry of Health, National Program for Medical Care of Persons Living with HIV/AIDS, Abidjan, Côte d'Ivoire.
  • Mohamed F; Elizabeth Glaser Pediatric AIDS Foundation, Abidjan, Côte d'Ivoire.
  • Shiraishi RW; Directorate General of Budget and Finance, Department of Economy and Finance, Abidjan, Côte d'Ivoire.
  • Sabatier J; Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Essombo J; Division of Global HIV & Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Adjorlolo-Johnson G; Elizabeth Glaser Pediatric AIDS Foundation, Abidjan, Côte d'Ivoire.
  • Marlink R; Elizabeth Glaser Pediatric AIDS Foundation, Los Angeles, California, United States of America.
  • Ellerbrock TV; Elizabeth Glaser Pediatric AIDS Foundation, Los Angeles, California, United States of America.
PLoS One ; 11(6): e0157059, 2016.
Article en En | MEDLINE | ID: mdl-27275742
ABSTRACT

BACKGROUND:

In Côte d'Ivoire, tuberculosis (TB) is a common cause of death among HIV-infected antiretroviral therapy (ART) enrollees. Ivorian guidelines recommend screening for TB and initiation of TB treatment before ART initiation. Compliance with these guidelines can help reduce TB-related mortality during ART and possibly nosocomial TB transmission. METHODS AND

FINDINGS:

In a retrospective cohort study among 3,682 randomly selected adults (≥15 years old) starting ART during 2004-2007 at 34 randomly selected facilities, documentation of TB screening completion, prevalence of active TB at ART initiation, and incidence of TB during ART were evaluated. At ART initiation, median age was 36 years, 67% were female, and median CD4 count was 135 cells/µL. Among all 3,682 enrollees, 73 (2%) were on TB treatment at the time of referral to the ART facility. Among the 3,609 not on TB treatment, 1,263 (36%) were documented to receive some TB screening before ART initiation; 21% were screened for cough, 21% for weight loss, 18% for fever, 18% for TB contacts, and 12% for night sweats. Among the 1,263 screened, 111 (11%) were diagnosed with TB and started TB treatment before ART. No associations between patient characteristics and probability of being screened were noted. However, documentation of TB screening completion before ART varied widely by ART facility from 0-100%. TB incidence during ART was 3.0 per 100 person-years but varied widely by ART facility from 0/100 person-year to 13.1/100 person-years.

CONCLUSIONS:

Screening for TB before ART initiation was poorly documented. Facility-level variations in TB screening documentation suggest facility-level factors, such as investment in training programs, might determine documentation practices. Targeting under-performing ART facilities with improvement activities is needed. Variations among facilities in TB incidence warrant further research. These incidence variations could reflect differences between facilities in TB screening, diagnostic tests, documentation practices, or TB risk possibly related to infection control practices or local community TB incidence.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / VIH-1 Tipo de estudio: Diagnostic_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tuberculosis / Infecciones por VIH / VIH-1 Tipo de estudio: Diagnostic_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Africa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos